Related Experiment Video
Updated: May 8, 2026
10:07
Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
Research Progress on Non-Coding RNA-Mediated Macrophage Polarization in Chronic Obstructive Pulmonary Disease
Ai Ma1, Xiaofeng Li1, Xiaoli Zeng2
1The First Clinical Medical College of Lanzhou University, Lanzhou, People's Republic of China.
Immunological Investigations
|May 7, 2026
Summary
Non-coding RNAs (ncRNAs) regulate macrophage polarization, a key factor in chronic obstructive pulmonary disease (COPD) pathogenesis. Targeting this axis offers potential for novel COPD biomarkers and therapies.
Area of Science:
- Immunology
- Molecular Biology
- Pulmonology
Background:
- Chronic obstructive pulmonary disease (COPD) is a complex respiratory disease with heterogeneous pathogenesis.
- Macrophages, key innate immune cells, critically regulate COPD through phenotypic polarization.
- Non-coding RNAs (ncRNAs) are crucial regulators of macrophage polarization and COPD progression.
Purpose of the Study:
- To comprehensively review the literature on ncRNAs regulating macrophage polarization in COPD.
- To analyze the molecular mechanisms underlying ncRNA-mediated macrophage polarization in COPD.
- To evaluate the potential of ncRNAs as biomarkers and therapeutic targets for COPD.
Main Methods:
- Systematic literature search on macrophage polarization, ncRNAs, and COPD.
- Analysis and synthesis of findings on ncRNA subtypes and their regulatory roles.
- Evaluation of ncRNA-based therapeutic strategies and challenges.
Main Results:
- ncRNAs finely orchestrate macrophage M1/M2 polarization via diverse mechanisms.
- ncRNAs influence COPD development and progression by modulating macrophage polarization.
- ncRNAs show promise as biomarkers and therapeutic targets for COPD.
Conclusions:
- Understanding ncRNA-macrophage polarization axis deepens COPD molecular insights.
- ncRNAs offer potential for precise COPD diagnosis, subtyping, and prognosis.
- Targeting ncRNAs presents new avenues for personalized COPD treatment.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.